Article
Reversion of High-level Mecillinam Resistance to Susceptibility in Escherichia coli During Growth in Urine.
EBioMedicine - 1 Sept 2017
Thulin Elisabeth, Thulin Måns, Andersson Dan I
Abstract excerpt
Mecillinam (amdinocillin) is a β-lactam antibiotic used to treat uncomplicated urinary tract infections (UTIs). We have previously shown that inactivation of the Escherichia coli cysB gene is the major cause of mecillinam resistance (MecR) in clinical isolates. In this study, we used different E. coli strains (laboratory and clinical isolates) that were MecR due to cysB mutations to determine how mecillinam...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
